Drug Patents owned by Slayback Pharma Llc

1. List of Prevduo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10456354 SLAYBACK PHARMA LLC Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
Oct, 2038

(15 years from now)

US11110054 SLAYBACK PHARMA LLC Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
Oct, 2038

(15 years from now)

Drugs and Companies using GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE ingredient

Market Authorisation Date: 23 February, 2023

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

2. List of Testosterone Cypionate drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11311554 SLAYBACK PHARMA LLC Pharmaceutical compositions of testosterone
Mar, 2039

(16 years from now)

Drugs and Companies using TESTOSTERONE CYPIONATE ingredient

Market Authorisation Date: 02 June, 2022

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR

More Information on Dosage

TESTOSTERONE CYPIONATE family patents

2

United States

1

India

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic